A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adults
Edgar T. Overton, Darja Schmidt, Sanja Vidojkovic, Erika Menius, Katrin Nopora, Jane Maclennan, Heinz Weidenthaler
Topics & Concepts
MedicineSeroconversionVaccinationAdverse effectImmunogenicityRandomized controlled trialVacciniaInternal medicineImmunologyAntibodyBiologyBiochemistryRecombinant DNAGenePoxvirus research and outbreaksBacillus and Francisella bacterial researchImmunotherapy and Immune Responses